Post on 26-Dec-2015
C. difficile Prevention Partnership Collaborative
Clostridium difficile Management in Healthcare Facilities
January 19, 2012
2
Clostridium difficile Management in Healthcare
Facilities
Phenelle Segal, RN CIC
Modification of Presentation by Gail Bennett, RN, MSN, CIC
3
Clostridium difficile Clostridium difficile Infection (CDI)Infection (CDI) - - ObjectivesObjectives
Describe the changing epidemiology of Clostridium difficile.
State two differences between acute care and long term care in managing patients/residents with C. difficile infection.
List three important strategies for preventing transmission of C. difficile within healthcare facilities.
4
Clostridium difficile Clostridium difficile Infection Infection (CDI) (CDI) Antibiotic induced diarrhea May cause approximately 30% of all cases
of healthcare associated diarrhea Most common cause of acute infectious
diarrhea in nursing homes Disease may be a nuisance or cause life
threatening pseudomembranous colitis Increasing numbers of cases
Cases tripled in US hospitals from 2000 until 2005
Increasing disease severity and mortality
Background: Impact
• Hospital-acquired, hospital-onset: 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths annually
• Hospital-acquired, post-discharge (up to 4 weeks): 50,000 cases, $0.3 billion in excess costs, and 3,000 deaths annually
• Nursing home-onset: 263,000 cases, $2.2 billion in excess costs, and 16,500 deaths annually
Campbell et al. Infect Control Hosp Epidemiol. 2009:30:523-33. Dubberke et al. Emerg Infect Dis. 2008;14:1031-8.
Dubberke et al. Clin Infect Dis. 2008;46:497-504. Elixhauser et al. HCUP Statistical Brief #50. 2008.
6
Clostridium difficile Clostridium difficile Colonization vs InfectionColonization vs Infection Colonization: presence of microorganisms
without tissue invasion or damage, therefore no signs or symptoms
Colonization rate of C. difficile About 10-25% of hospitalized patients About 4-20% of long term care residents Antibiotic therapy may disrupt normal colonic flora in
colonized patients and C. difficile proliferates, producing toxins and symptomatic disease
Infection: presence of microorganisms with tissue invasion and damage, therefore signs or symptoms
7
Background: EpidemiologyRisk Factors
Antimicrobial exposure Acquisition of C. difficile Advanced age Underlying illness Immunosuppression Tube feeds ? Gastric acid suppression
Main modifiable risk factors
8
Antibiotics most often associated with Clostridium difficile
Ampicillin Amoxicillin Cephalosporins Clindamycin Fluoroquinolones
9
Testing for Clostridium difficile
Toxin testing Quick – same day
Stool culture Takes 48-96 hours
Testing for C. difficile should be done on unformed (liquid) stool only unless ileus is suspected
10
Treatment Options
Discontinue antibiotics if possible Fluid and electrolyte replacement Do not use antimotility agents (e.g. opiates) Metronidazole (Flagyl) 250 mg QID or 500 mg TID
for 10-14 days Vancomycin 125 mg QID for 7-10 days - used if
resident does not respond to or cannot take Flagyl; may be used first if severe disease
New drug: Dificid (Fidaxomicin) – 200 mg bid for 10 days
Experimental fecal transplant (enemas)
11
Recurrent Clostridium difficile infection
Rates of recurrence 20% after 1st episode 45% after 1st recurrence 65% after two or more recurrences
12
C. difficile in Acute vs. Non-acute Settings
13
Tiered Approach to Clostridium difficile Infection (CDI) Transmission Prevention
Basic/Core/Routine Approach: C. difficile transmission prevention activities during routine infection prevention and control responses
Enhanced/Supplemental/Heightened Approach: C. difficile transmission prevention activities during heightened infection prevention and control responses
Evidence of ongoing transmission of C. difficile an increase in CDI rates and/or evidence of change in the pathogenesis of CDI (increased
morbidity/mortality among CDI patients) despite routine preventive measures
Note: many facilities choose to use the enhanced/supplemental approach all of the time.
14
Infection Prevention Strategies
Hand hygieneHand hygiene Contact precautionsContact precautions Identification of casesIdentification of cases Environmental disinfection Appropriate use of antibiotics
15
For basic measures, may use alcohol handrubs with C. difficile – OR use soap and water
Perform hand hygiene
before contact with the patient/resident
after removing gloves after contact with the
environment
Hand Hygiene for Clostridium difficile
Hand Hygiene – Soap vs. Alcohol gel
Alcohol not effective in eradicating C. difficile spores
However, one hospital study found that from 2000-2003, despite increasing use of alcohol hand rub, there was no concomitant increase in CDI rates
Discouraging alcohol gel use may undermine overall hand hygiene program with untoward consequences for HAIs in general
Boyce et al. Infect Control Hosp Epidemiol 2006;27:479-83.
CDC adds: Because alcohol does not kill Clostridium
difficile spores, use of soap and water is more efficacious than alcohol-based hand rubs.
However, early experimental data suggest that, even using soap and water, the removal of C. difficile spores is more challenging than the removal or inactivation of other common pathogens.
17
18
For enhanced measures, do not use alcohol handrubs with the CDI patient/resident – use soap and water
Washing away the spores may be the optimal way to perform hand hygiene when transmission of C. difficile is occurring
Many facilities choose to use the enhanced strategy all of the time
Hand Hygiene for Clostridium difficile (continued)
19
Infection Prevention Strategies
Hand hygiene Contact precautions Identification of casesIdentification of cases Environmental disinfection Appropriate use of antibiotics
20
Contact PrecautionsContact Precautions
Designed to reduce the risk of transmission of microorganisms by direct or indirect contact
Direct contact skin-to-skin contact physical transfer (turning patients/residents,
bathing patients, other patient/resident care activities)
Indirect contact Contaminated objects
Equipment Linens High touch surfaces
21
Patient or Resident placement Private room preferred 2nd option: Cohorting with other patient/resident with
C. difficile 3rd option: In LTCFs, consider infectiousness and
resident-specific risk factors to determine rooming with a low risk roommate and socializing outside the room
Consider: Clean Contained Cooperative Cognitive
Patient care equipment dedicated to single patient/resident if possible. If not, disinfect equipment prior to leaving the room.
Contact PrecautionsContact Precautions
22
Tiered Approach for Contact Precautions: Basic
Contact Precautions - gloves and gowns to enter room or cubicle
Do not re-use gowns Supplies outside the room
Tiered Approach for Contact Precautions: Basic (continued)
In semi-private room, keep cubicle curtain drawn to limit movement between cubicles and as a reminder of precautions
23
24
Contact Precautions: Basic Contact Precautions: Basic (Continued)(Continued)
Use dedicated equipment; if not feasible – decontaminate prior to use on another patient/resident
Maintain adequate supplies for contact precautions
Do not isolate asymptomatic carriers
25
Contact Precautions: Basic Contact Precautions: Basic (Continued)(Continued)
May discontinue precautions when diarrhea ceases (may consider 48 hours without loose stool)
Do not do a toxin “for cure” once diarrhea has stopped
Lab should not accept stool for toxin if the stool is formed
26
After treatment, repeat C. difficile testing is not recommended if the patient’s symptoms have resolved, as patients may remain colonized.
http://www.cdc.gov/ncidod/dhqp/id_CdiffFAQ_HCP.html
From the Horse’s Mouth:CDC’s Web Site
27
Tiered Approach for Contact Precautions: Enhanced
May consider alternative signage to ensure staff awareness
Evaluate current system for patient/resident placement
Consider contact precautions for all patients/residents that develop diarrhea until CDI is ruled out
Increase monitoring of isolation precautions and hand hygiene
Extend use of contact precautions even when diarrhea stops
28
Why contact precautions for Why contact precautions for C. C. difficiledifficile????
Environmental contamination
29
The Inanimate Environment Can Facilitate Transmission
~ Contaminated surfaces increase cross-transmission ~Abstract: The Risk of Hand and Glove Contamination after Contact with a VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL.
X represents VRE culture positive sites
30
Signage for Precautions
31
Infection Prevention Strategies
Hand hygieneHand hygiene Contact precautionsContact precautions Identification of casesIdentification of cases Environmental disinfection Appropriate use of antibiotics
32
Identification of Cases
Colonization or asymptomatic fecal carriage of C. difficile May be common in healthcare
facilities Do we care?
C. difficile infection Acute diarrhea
33
CDI Collaborative Definition A case of C. difficile is defined as a case with
the symptom of diarrhea without other known etiology
The stool sample will yield a positive result for laboratory assay for C. difficile toxin A and/or B
For this collaborative, CDI is limited to lab confirmed cases
Will track healthcare associated CDI
34
CDI Collaborative Definition of Healthcare Associated
This collaborative will track laboratory confirmed cases of Health Care Facility C. difficile.
A laboratory confirmed case of C. difficile is defined as a patient with diarrhea characterized by unformed stool, without other known etiology, and associated with a positive laboratory assay for C. difficile toxin A and/or B on the stool.
Count each case of CDI only once Recurrent CDI: Episode of CDI that occurs eight weeks
or less after the onset of a previous episode, provided the symptoms from the prior episode resolved.
35
Definition (continued)HAI-CDI (INDEX FACILITY)A patient classified as having a case of healthcare facility associated C. difficile attributable to YOUR facility is defined as a patient who develops diarrhea on or after the 4th day of admission.ORA patient classified as having any symptoms that develop on or before the 4th day after your discharge to another healthcare facility. ORA patient discharged to home with lab confirmed C.diff. within 28 days from the day of discharge and no intervening admissions. (Day of discharge counts as day 1) Also counts if C.diff is identified on readmission to your facility within that 28 day period.
36
Definition (continued)
HAI-CDI (OTHER FACILITY)A patient classified as having a case of healthcare facility associated C. difficile attributable to another health care facility is defined as a patient who develops diarrhea before the 4th day of admission
after transfer from another health care facility OR:
within 28 days of discharge from another health care facility
37
48 hours - example Admission = day 1 – Monday Day 2- Tuesday Day 3- Wednesday Day 4- Thursday at 12:01 a.m. is the
cutoff. After Thursday at 12:01, it counts for your facility. Prior to that time, it is considered “community acquired” which includes any location other than your facility.
Exception – home care – 28 days
38
Facility Healthcare Associated CDI Rate # of HA CDI cases divided by
patient/resident days X 10,000 = ___ HA CDI per 10,000 patient/resident days
Example: 3 cases HA CDI divided by 3,585
patient/resident days = .0008368 X 10,000 =8.368 or 8.4 cases of HA CDI per 10,000 patient/resident days
39
40
Identification of Cases
Basic Strategy: With cases of diarrhea, consider C.
difficile Take a detailed history for risk factors
Norovirus, dietary changes, medications, and other things may also be causes of diarrhea
Notify physician Watch for dehydration
41
Identification of Cases
Enhanced Strategy: Automatic contact precautions for all
patients/residents with orders for C. difficile labs AND for all patients/residents with a known history of CDI
Consider allowing nurses to initiate the lab order and contact precautions
Consider universal glove usage on units that have a high incidence/rate of CDI
42
Infection Prevention Strategies Contact precautions Hand hygiene Identification of casesIdentification of cases Environmental disinfection Appropriate use of antibiotics
43
Environmental Survival and Contamination
Vegetative form survives for only 15 minutes on dry surfaces in room air May remain viable up to 6 hours on moist
surfaces Spores are highly resistant to drying, heat, and
chemical and physical agents Can exist for five months on hard surfaces
One study (McFarland et al, 1989) found spores in: 49% of rooms occupied with CDI 29% in rooms of asymptomatic carriers
44
Environmental Survival and Contamination (continued)
Heaviest contamination on floors and in bathrooms but ALL surfaces have the ability to be contaminated
Spores have been isolated from the air and aerosol dissemination may, in part, account for widespread environmental contamination
The frequency of positive personnel hand culture has been strongly correlated with the intensity of environmental contamination
45
Evidence of the role of environmental transmission
Frequency of C. difficile acquisition has been linked with the level of environmental contamination
Patients admitted to a room previously occupied by a patient with C. difficile have a higher risk for C. difficile acquisition
Improved room disinfection has led to decreased rates of C. difficile infection
Monitor environmental cleaning
Environmental Disinfection: Tiered Approach
Basic:Use EPA approved
germicide for routine disinfection during non-outbreak situations
Ensure staff training and contact time
Disinfect shared items between patients/residents
Enhanced:Use 10% sodium
hypochlorite (bleach) for disinfecting room and equipment (or use EPA registered sporicidal agent)
In outbreak, consider bleach solution for cleaning all rooms
Use bleach wipes as an adjunct to cleaning
47
Disinfectants
Commonly used disinfectants are not sporicidal Some may actually encourage sporulation
(the changing of the organism to the spore state)
Sporicidal disinfectants: Chlorine-based disinfectants High-concentration, vaporized hydrogen
peroxide Recently approved EPA registered
disinfectants that kill C. diff spores
48
Disinfectants
Chlorine-based disinfectants - disadvantages: Can be corrosive to equipment or surfaces over
time Can cause respiratory or other health problems in
workers using them May cause bleaching/fading Reconstituted product needs to be made fresh daily
APIC states use of chlorine-based disinfectants should be limited to outbreak situations and when high rates of CDI have been documented
In these situations (outbreaks and/or high rates), chlorine-based products have demonstrated benefit when used with other control measures
49
Pre-mixed Hypochlorite Solution: Advantages and Disadvantages
Advantages: Commercially available solutions include
detergent base Cleaning as well as disinfection Eliminates dilution errors
Disadvantages of pre-mixed solutions: Solutions expire over time May be hard to store May be more costly
50
Bleach and water: mixing your own solution
Cleaning and disinfection is a two-step process (must clean first, then disinfect)
Contact time of ten minutes required for disinfection (Rutala, 2008) Thorough wetting of the surface, allowed to
air dry Note: pre-mixed EPA registered
hypochlorite solutions provide cleaning and disinfection in one step
51
Floor decontamination Consider cleaning the C. difficile room
as the last room of the day Alternately, if not using microfiber
mops, change the bucket, solution, and mop head after cleaning the C. difficile room and before cleaning another room
All cleaning equipment and supplies should be decontaminated prior to use on another room
52
Germicidal Wipes If wipes are used:
The wipe must wet the surface being disinfected for the correct contact time as noted on label
Use the right wipes for the right type of job The user should:
Know the contact time for the germicide used Know the ability of the wipe to maintain contact
time for the task for it will be used Be involved in selection of the right type of wipes
Staff must be trained to use the wipes appropriately
53
Additional thought.. Remember the cubicle curtains when doing
terminal cleaning following C. difficile infection
54
Monitoring Environmental Cleaning
Consistency with recommended cleaning and disinfection procedures should be routinely monitored.
Include all surfaces and items near the patient Staff performing cleaning should use checklists
Confirm that each critical area has been cleaned and disinfected
Each item must be checked off as it is completed No need for routine environmental sampling for
Clostridium difficile If there is ongoing transmission:
May indicate non-compliance Thorough cleaning and disinfection of the
environment must be done
55
56
APIC Guide
57
Environmental Services Training
Because of the high turnover of staff, educate personnel on proper cleaning technique frequently.
Ensure that education is provided in the personnel’s native language.
58
Infection Control Strategies
Contact precautions Hand hygieneHand hygiene Identification of casesIdentification of cases Environmental disinfection Appropriate use of antibiotics
59
Antimicrobial Stewardship: definition
Antimicrobial (or antibiotic) stewardship programs are interventions designed to ensure that hospitalized patients receive the right antibiotic, at the right dose, at the right time, and for the right duration (CDC definition)
60
Prescriber educationStandardized antimicrobial order
formsFormulary restrictionsPrior approval to start/continue
61
Pharmacy substitution or switch Multidisciplinary drug utilization
evaluation (DUE)Provider/unit performance feedback Computerized decision support/on-
line ordering
62
CDC Fast Facts
Antibiotic overuse contributes to the growing problems of Clostridium difficile infection and antibiotic resistance in healthcare facilities.
Improving antibiotic use through stewardship interventions and programs improves patient outcomes, reduces antimicrobial resistance, and saves money.
Interventions to improve antibiotic use can be implemented in any healthcare setting—from the smallest to the largest.
Improving antibiotic use is a medication-safety and patient-safety issue.
http://www.cdc.gov/getsmart/healthcare/inpatient-stewardship.html
63
Antibiotic Review for Long Term Care Facilities
F441: Because of increases in MDROs, review of the use of antibiotics is a vital aspect of the infection prevention and control program.
An area of increased surveyor focus - an area where you need to assess if you are meeting the surveyor guidance
64
42 CFR §483.25(l), F329, Unnecessary Drugs Determine if the facility has reviewed with
the prescriber the rationale for placing the resident on an antibiotic to which the organism seems to be resistant or when the resident remains on antibiotic therapy without adequate monitoring or appropriate indications, or for an excessive duration
65
What most likely exists currently in your program: Comparison of prescribed antibiotics with available
susceptibility reports (charge nurse and infection preventionist)
Review of antibiotics prescribed to specific residents during regular medication review by consulting pharmacist
What may be needed: Antibiotic stewardship program in the facility (CDC
recommendation – 2006 MDRO guideline) Broader overview of antibiotic use in your facility with
reporting to quality assurance/infection control committee
Right drug - Right dosage - Right monitoring - Feedback of data to MDs
66
Monitoring of practices is crucial! We must observe to see that our policies and
recommended processes are being done and done correctly
Educate staff or use other appropriate measures when you see non-compliance She doesn’t know She doesn’t care It won’t work
Enforce that all staff must follow the rules for contact precautions and hand hygiene
Conversation and Questions
Thinking about your cleaning processes:
What do you think is working well?
Where could you use help? Questions?
68
References Clinical Practice Guidelines for
Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
http://azdhs.gov/phs/oids/epi/disease/cdif/documents/Clinical%20Practice%20Guidelines%20for%20C%20Diff%20Infection%20%202010%20update%20by%20SHEA-IDSA.pdf
69
References APIC Guide to the Elimination of
Clostridium difficile Infections in Healthcare Settings. http://www.apic.org/Content/NavigationMenu/PracticeGuidance/APICEliminationGuides/C.diff_Elimination_guide_logo.pdf
SHEA: Clostridium difficile in Long Term Care Facilities for the Elderly http://www.shea-online.org/Assets/files/position_papers/SHEA_Cdiff.pdf
70
References (continued)
Spotlight on Clostridium difficile Infection: An Educational Resource for Pharmacists
David P. Nicolau , PharmD, FCCP, FIDSAhttps://secure.pharmacytimes.com/lessons/200902-02.asp
71
CDI Toolkit – CDC
Clostridium difficile (CDI) Infections Toolkit (pdf) http://www.cdc.gov/hai/organisms/cdiff/cdiff_infect.html
CDI Toolkit available in PowerPoint format
on the CDC website Clostridium Difficile Infection (CDI) Baseline
Prevention Practices Assessment Tool For States Establishing HAI Prevention Collaboratives Using ARRA Funds Using Recovery Act Funds
http://www.cdc.gov/HAI/recoveryact/stateResources/toolkits.html
72
Protect patients…protect healthcare personnel…promote quality healthcare!
Thank you! gailbennett@icpassociates.com
PreventionIS PRIMARY!
If you haven’t yet…Register for Regional Meetings
Lowell General Hospital—January 24 Baystate Medical Center—January 25 Jordan Hospital—January 26 UMASS Memorial Medical Center—January 31 Register at:
https://www.regonline.com/cdifficilepreventioncollaborativeregionalworkshops